Development Center for Biotechnology

Dcb-usa LLC

Yu-Shen Hsu

Ta-Tung Yuan

Young-Sun Lin

Ming-Chuan Chang

Cheng-Kai Lo

Jiu-Yao Wang

Kuo-Chan Hung

Yuan-Hsin Lu

Show-Shan Sheu

I-Ling Kou

Ming-I Chang

A detoxified recombinantheat-labile enterotoxin mutant, LTS61K, is employed as a carrier protein to conjugate polysaccharide. The LTS61K contains a mutated mature sub-unit A (LTA) that includes lysine at amino acid position 61 and a wild-type mature sub-unit B (LTB). Various types of bacterial capsular polysaccharide antigens were chemically conjugated with the LTS61K protein by a reductive amination reaction. The conjugated polysaccharide-LTS61K products were physically, chemically and biochemically identified as soluble form. Rabbits were immunized intramuscularly to determine the immunogenicity of conjugated vaccines by ELISA to detect anti-polysaccharide antigen IgG titers and serum bactericidal assay thereby determining the functional activity of the antibodies. Study results show that conjugated polysaccharide-LTS61K vaccines induce higher polysaccharide-specific IgG titers and greater bactericidal activity in sera than that of polysaccharide alone or polysaccharide mixed with LTS61K. The presence of anti-LTS61K serum IgG antibody alleviates travel diarrhea caused by(ETEC enterotoxigenic).

Polysaccharide conjugation with detoxifiedheat labile enterotoxin (LT) used as vaccine

This invention relates to bispecific antibodies having combinations of linker and hinge sequences to create linker-hinge interface domains with biological significance. Such linker-hinge interface domains covalently join two molecules, maintain the biological activities of linked molecules (target binding), stabilize the biological characteristics of new molecule (solubility and 4&#xb0; C. stability), maintain the chemical, biochemical and physical properties (cytotoxicity) of the linked molecules, and modulate the biological characteristics of the linked molecules (activating T-lymphocytes without significant sign of proliferations). Both linker (GGGGS) and hinge (CPPCP) sequences are required to establish functional linker-hinge interface domains as deletion of any of the component resulted in significant lost of T-lymphocyte mediated activity.

Bispecific T-cell activator antibody

A method for treating allergy with a pharmaceutical composition containing a detoxifiedheat-labile enterotoxin, and, optionally, an allergen.

[object Object]

This invention relates to a mutantheat-labile enterotoxin (LT) subunit A that can be used as an adjuvant. This subunit A mutant contains an amino acid substitution at a position corresponding to position 61 of a wild-type LT. An LT containing this mutated subunit A exhibits reduced toxicity compared to its wild type counterpart.

Growing community of inventors

Xizhi, Taiwan

Yu-Shen Hsu